Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreYour world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreFor government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MORE
In an effort to guide companies in prevention and reduction of fraud and abuse in federal healthcare programs, the government has outlined the fundamental principles that it believes are imperative to an effective healthcare compliance program.
IQVIA can assist you in assessing, designing, implementing and/or managing a healthcare compliance program that incorporates industry best practices, guidelines set forth in the U.S. Federal Sentencing Guidelines, the Department of Health and Human Services Office of Inspector General’s (“OIG’s”) Compliance Program Guidance for Pharmaceutical Manufacturers (also applicable to device manufacturers), and other government pronouncements which could be applicable.
Companies can outsource to IQVIA all compliance functions or simply pursue an “a la carte” approach to fill specific compliance needs or gaps. Services include:
In addition, we offer a full suite of outsourced Transparency (aka “Sunshine” or “Aggregate Spend”) services. For budgets big and small, we have an option that will work for you.
Contact us and let’s put our expertise to work for you.
Promote continuous improvement
Robust compliance programs to reduce your current and future exposure
Drive compliance and accountability with your sampling program.
Responding to FDA enforcement.
A structured approach for characterizing and optimizing quality systems.
Keeping your organization safe without compromising patient care.
Take the work and risk out of compliance.
Reduce your administrative burden with our state licensing services.
Easing the path to compliance and reporting with technology.
